Page last updated: 2024-08-21

hydrazine and Stroke

hydrazine has been researched along with Stroke in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Balloova, A; Chupakhin, O; Dremencov, E; Grinchii, D; Kiss, A; Kochetkov, A; Mach, M; Osacka, J; Paliokha, R; Rantsev, M; Sarapultsev, A; Sarapultsev, P; Sidorova, L; Spasov, A; Vassiliev, P1
Maeda, Y; Tamai, Y; Yamamoto, D1
Lapeyre-Mestre, M; Montastruc, F; Moulis, G; Nguyen, TT; Palmaro, A1
Ahmad, AS; Candelario-Jalil, E; DeMars, KM; Doré, S; Frankowski, JC; Hawkins, KE; Leclerc, JL; Yang, C1
Inoue, K; Leng, T; Ueki, T; Xiong, ZG; Yang, T; Zeng, Z1
Fu, N; Fu, Y; Shao, J; Shen, F; Xia, W; Yan, A; Yang, X; Zhang, T1

Other Studies

6 other study(ies) available for hydrazine and Stroke

ArticleYear
Combined In Silico, Ex Vivo, and In Vivo Assessment of L-17, a Thiadiazine Derivative with Putative Neuro- and Cardioprotective and Antidepressant Effects.
    International journal of molecular sciences, 2021, Dec-20, Volume: 22, Issue:24

    Topics: Animals; Antidepressive Agents; Computer Simulation; Depression; Hippocampus; Hydrazines; Male; Myocardial Infarction; Neurons; Neuroprotective Agents; Protective Agents; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Stroke

2021
Eltrombopag-induced recurrent stroke in idiopathic thrombocytopenic purpura.
    BMJ case reports, 2021, Mar-29, Volume: 14, Issue:3

    Topics: Benzoates; Humans; Hydrazines; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Stroke

2021
Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase®.
    Drug safety, 2015, Volume: 38, Issue:12

    Topics: Adverse Drug Reaction Reporting Systems; Aging; Benzoates; Humans; Hydrazines; Myocardial Infarction; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Risk Factors; Stroke; Thrombopoietin; Thrombosis

2015
Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.
    Scientific reports, 2015, Dec-09, Volume: 5

    Topics: Animals; Blood-Brain Barrier; Brain Infarction; Disease Models, Animal; Endothelial Cells; Gene Expression; Gene Knockout Techniques; Hydrazines; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Neurons; Neutrophil Infiltration; Oxazepines; Permeability; Proteolysis; Rats; Receptors, Prostaglandin E, EP1 Subtype; Stroke; Tight Junction Proteins

2015
Role of serum- and glucocorticoid-inducible kinases in stroke.
    Journal of neurochemistry, 2016, Volume: 138, Issue:2

    Topics: Animals; Benzamides; Glucocorticoids; Hydrazines; Immediate-Early Proteins; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Stroke; Ubiquitin-Protein Ligases

2016
Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury.
    Scientific reports, 2016, 10-24, Volume: 6

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cytokines; Disease Models, Animal; Fatty Acids, Unsaturated; Gliosis; Hydrazines; Macrophage Activation; Mice, Inbred ICR; Receptors, Thromboxane A2, Prostaglandin H2; Reperfusion Injury; Stroke; Treatment Outcome

2016